| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |